| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.007 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |